These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20694690)

  • 21. Biotinylated peptides for rapid identification of substrates and inhibitors of kinases and phosphatases with fluorescence superquenching.
    Wittenburg S; Stankewicz C; Rininsland F
    Assay Drug Dev Technol; 2006 Oct; 4(5):535-43. PubMed ID: 17115924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of selective class II histone deacetylase inhibitors using a novel dual-parameter binding assay based on fluorescence anisotropy and lifetime.
    Haus P; Korbus M; Schröder M; Meyer-Almes FJ
    J Biomol Screen; 2011 Dec; 16(10):1206-16. PubMed ID: 22027638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy.
    Bridges AJ
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):343-5. PubMed ID: 15787602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bioluminogenic HDAC activity assay: validation and screening.
    Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
    J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
    Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
    J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies in developing promising histone deacetylase inhibitors.
    Zhang L; Fang H; Xu W
    Med Res Rev; 2010 Jul; 30(4):585-602. PubMed ID: 19634125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond protein binding: recent advances in screening DNA-encoded libraries.
    Kodadek T; Paciaroni NG; Balzarini M; Dickson P
    Chem Commun (Camb); 2019 Nov; 55(89):13330-13341. PubMed ID: 31633708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for mapping protease specificity.
    Diamond SL
    Curr Opin Chem Biol; 2007 Feb; 11(1):46-51. PubMed ID: 17157549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array-on-Array Strategy For Activity-Based Enzyme Profiling.
    Sieow BF; Uttamchandani M
    Methods Mol Biol; 2017; 1518():131-138. PubMed ID: 27873204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.
    Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R
    BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting protein-small molecule interactions using fluorous small-molecule microarrays.
    Vegas AJ; Koehler AN
    Methods Mol Biol; 2010; 669():43-55. PubMed ID: 20857356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying small molecule microarrays and resulting affinity probe cocktails for proteome profiling of mammalian cell lysates.
    Shi H; Uttamchandani M; Yao SQ
    Chem Asian J; 2011 Oct; 6(10):2803-15. PubMed ID: 21898842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial discovery of fluorescent pharmacophores by multicomponent reactions in droplet arrays.
    Burchak ON; Mugherli L; Ostuni M; Lacapère JJ; Balakirev MY
    J Am Chem Soc; 2011 Jul; 133(26):10058-61. PubMed ID: 21644551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme assay design for high-throughput screening.
    Williams KP; Scott JE
    Methods Mol Biol; 2009; 565():107-26. PubMed ID: 19551359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2D and 3D cell microarrays in pharmacology.
    Gidrol X; Fouqué B; Ghenim L; Haguet V; Picollet-D'hahan N; Schaack B
    Curr Opin Pharmacol; 2009 Oct; 9(5):664-8. PubMed ID: 19520607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
    Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
    J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-throughput turbidometric assay for screening inhibitors of Leishmania major protein disulfide isomerase.
    Ben Khalaf N; De Muylder G; Ratnam J; Kean-Hooi Ang K; Arkin M; McKerrow J; Chenik M
    J Biomol Screen; 2011 Jun; 16(5):545-51. PubMed ID: 21441416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.